What is the management of anaphylaxis in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Anaphylaxis in Pregnancy

Anaphylaxis in pregnancy should be managed with the same aggressive treatment principles as in non-pregnant patients, with immediate intramuscular epinephrine as first-line therapy, aggressive fluid resuscitation, and left uterine displacement to prevent aortocaval compression. 1

Immediate Management

Epinephrine Administration

  • Administer epinephrine 1:1000 (1 mg/mL) at 0.5 mg (0.01 mg/kg) intramuscularly into the mid-outer thigh (vastus lateralis) immediately 1, 2
  • Repeat every 5 minutes as necessary to control symptoms and blood pressure 1
  • There is no absolute contraindication to epinephrine in pregnancy—the benefits to both mother and fetus far outweigh theoretical risks 3, 2
  • The FDA classifies epinephrine as Pregnancy Category C, but it remains the drug of choice for anaphylaxis during pregnancy 3

Critical Positioning

  • Position the parturient with left uterine displacement to avoid aortocaval compression—this is essential and unique to pregnant patients 1
  • Place patient in recumbent position with lower extremities elevated 1, 4

Fluid Resuscitation

  • Administer crystalloid fluids (normal saline) at 20 mL/kg as rapid bolus, repeated as needed 1
  • Large volumes may be necessary—up to 30 mL/kg in the first hour 1
  • For persistent hypotension, consider colloid-containing solutions 1

Airway and Oxygen

  • Assess and maintain airway patency (endotracheal intubation or cricothyrotomy may be required) 1, 4
  • Administer oxygen at 6-8 L/min 1, 4
  • Establish venous access immediately 1, 4

Graded Response Based on Severity

Grade II Reactions (Moderate)

  • Epinephrine 20 mcg IV bolus initially 1
  • If inadequate response at 2 minutes, escalate to 50 mcg 1
  • 500 mL crystalloid rapid bolus, repeat as needed 1

Grade III Reactions (Severe)

  • Epinephrine 50 mcg IV bolus, or 100 mcg if inadequate response to other vasopressors 1
  • 1 L crystalloid rapid bolus 1
  • If inadequate response at 2 minutes, escalate to 200 mcg 1
  • Repeat fluid boluses up to 30 mL/kg 1

Grade IV Reactions (Cardiac Arrest)

  • Epinephrine 1 mg IV, repeat per advanced life support guidelines 1
  • Consider extracorporeal membrane oxygenation (ECMO) if systolic BP <50 mmHg or end-tidal CO2 <3 kPa 1

Obstetric Considerations

Emergency Delivery Decisions

  • Consider emergent cesarean section early if there is persistent hypotension despite aggressive resuscitation 1
  • Perimortem cesarean delivery should be initiated if persistent hypotension after 4 minutes of cardiac arrest 1
  • Delivery of the fetus should be performed 1 minute later (at 5 minutes) if usual resuscitation measures have not achieved return of spontaneous circulation 1
  • This improves outcomes for both mother (relieves aortocaval compression, improving resuscitation effectiveness) and neonate 1, 5

Second-Line Adjunctive Therapies

Antihistamines (Second-Line Only)

  • Diphenhydramine 25-50 mg IV or 1-2 mg/kg parenterally 4
  • Consider ranitidine 50 mg IV (1 mg/kg) diluted and administered over 5 minutes 4
  • Never use antihistamines as first-line therapy or alone—they are adjuncts only 4

Bronchodilators

  • Nebulized albuterol 2.5-5 mg in 3 mL saline if bronchospasm persists despite epinephrine 4

Corticosteroids

  • Consider systemic glucocorticosteroids for patients with asthma or severe/prolonged anaphylaxis 1, 4
  • Methylprednisolone 1.0-2.0 mg/kg/day IV every 6 hours, or oral prednisone 0.5 mg/kg for less critical episodes 4
  • Corticosteroids are not helpful acutely but may prevent biphasic or protracted reactions 4

Refractory Hypotension

  • If hypotension persists despite epinephrine and fluids, consider vasopressors such as dopamine 2-20 mcg/kg/min 4
  • Glucagon 1-5 mg IV (20-30 mcg/kg in children, max 1 mg) over 5 minutes followed by infusion (5-15 mcg/min) if patient is on beta-blockers 1, 4

Common Triggers in Pregnancy

  • Beta-lactam antibiotics (58% of cases), latex (25%), and anesthetic agents (17%) are the most common causes during cesarean section 6
  • 49-74% of anaphylaxis cases in pregnancy occur during cesarean section 6
  • Neuromuscular blocking agents are also commonly implicated 1

Critical Pitfalls to Avoid

  • Delaying epinephrine administration is the most common and dangerous error—epinephrine must be given immediately 4, 2
  • Failing to position patient with left uterine displacement worsens both maternal hypotension and fetal compromise 1
  • Using antihistamines or corticosteroids as first-line treatment instead of epinephrine 4
  • Inadequate fluid resuscitation—pregnant patients may require very large volumes 1
  • Failing to consider early cesarean delivery in severe cases with persistent hypotension 1, 5
  • Withholding epinephrine due to pregnancy concerns—prompt maternal resuscitation is essential for good outcomes for both mother and fetus 1, 3

Post-Acute Management

  • Observe in monitored area for minimum 6 hours from onset of reaction 1
  • Most patients with Grade III-IV reactions require ICU admission 1
  • Prescribe epinephrine auto-injector and provide education on self-administration 1, 4
  • Refer to allergist-immunologist for comprehensive evaluation and allergy testing to identify specific trigger 1, 4, 6
  • Advise patient to wear medical identification (Medic Alert jewelry) 1, 4

Special Considerations

  • Anaphylaxis-induced hyperfibrinolysis can occur and may exacerbate postpartum hemorrhage—monitor coagulation parameters 7
  • Concomitant beta-blocker therapy increases risk of severe reactions and may require glucagon 1, 4
  • The frequency of anaphylaxis during pregnancy is estimated at 1.5-3.8 per 100,000 pregnancies 6
  • With appropriate and timely management, even severe anaphylaxis can result in excellent maternal and fetal outcomes 2, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute management of anaphylaxis in pregnancy.

Australian journal of general practice, 2022

Guideline

Management of NSAID-Induced Anaphylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anaphylaxis and Pregnancy: A Systematic Review and Call for Public Health Actions.

The journal of allergy and clinical immunology. In practice, 2021

Research

Anaphylaxis-induced hyperfibrinolysis in pregnancy.

International journal of obstetric anesthesia, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.